김치경 교수의 진료시간표

김치경 교수의 상세정보

학회활동

• 2006 .03 .01 ~   :  대한신경과학회 (정회원)
• 2008 .03 .01 ~   :  대한뇌졸중학회 (정회원)
• 2009 .03 .01 ~   :  American Heart Association (professional member)
• 2013 .03 .01 ~   :  대한중환자의학회 (평생회원)
• 2013 .03 .01 ~   :  대한신경집중치료학회 (재무간사)
• 2015 .03 .01 ~   :  European Stroke Organisation
• 2016 .03 .01 ~   :  대한신경초음파학회 (총무간사)
• 2017 .05 .01 ~   :  한국뇌졸중의학연구원 (이사)
• 2018 .02 .01 ~   :  한국생체재료학회 (학술위원)
• 2018 .05 .01 ~   :  World Stroke Organization
• 2018 .11 .01 ~   :  대한고혈압학회 (평생회원)
• 2020 .01 .01 ~   :  대한치매학회 (정회원)

국외활동

• 2018 .09 .22 ~  2018 .09 .22 :  Asian Interchange in Stroke (Manila, Philippines) Management of emergency cases of patients on NOACs (invited speaker: symposium)
• 2015 .10 .08 ~  2015 .10 .08 :  Calgary Stroke Program Academic Lecture (Calgary, Canada): Application of nanobiomaterials for stroke theragnosis. (Invited lecture)
• 2014 .02 .12 ~  2014 .02 .14 :  International Stroke Conference 2014 (San Diego, USA): Ceria nanoparticles begin: new therapeutic nanomaterials against ischemic stroke (Invited speaker: Symposium)
• 2018 .04 .12 ~  2018 .04 .12 :  The 27th European Stroke Conference (Athens, Greece) Anti-apoptotic and anti-inflammatory effects of sildenafil on neuronal cells and endothelial cells exposed to oxygen-glucose deprivation (Oral Presentation)
• 2018 .04 .11 ~  2018 .04 .11 :  The 27th European Stroke Conference (Athens, Greece) Insulin resistance as a poor prognostic marker in non-diabetic ischemic stroke (Oral Presentation)
• 2017 .10 .21 ~  2017 .10 .21 :  The 8th Japan-Korea Joint Stroke Conference (Niigata, Japan): Acute-phase brain natriuretic peptide as a marker of poor prognosis of ischemic stroke related to atrial fibrillation with preserved ejection fraction. (Oral Presentation)
• 2016 .10 .30 ~  2016 .11 .01 :  13th International Symposium on Thrombolysis Thrombectomy and Acute Stroke Therapy (Kobe, Japan): Resistant hypertension as a poor prognosticator for acute ischemic stroke. (Oral Presentation)
• 2015 .04 .17 ~  2015 .04 .19 :  The European Stroke Organisation Conference 2015 (Glasgow, UK): Impact of adherence with antihypertensive therapy on the mortality after ischemic stroke: a nationwide multicenter follow-up study. (Oral Presentation)
• 2014 .02 .12 ~  2014 .02 .14 :  International Stroke Conference 2014 (San Diego, USA): Effect of long-term treatment with fimasartan on transient focal ischemia in rat brain. (Oral Presentation)
• 2015 .02 .11 ~  2015 .02 .13 :  International Stroke Conference 2015 (Nashville, USA): Impact of adherence with antiplatelet monotherapy on the mortality after ischemic stroke: a nationwide multicenter follow-up study. (Oral Presentation)
• 2014 .02 .12 ~  2014 .02 .14 :  International Stroke Conference 2014 (San Diego, USA): Effect of warfarin adherence on the mortality after ischemic stroke: a nationwide multicenter cohort study. (Oral Presentation)
• 2012 .02 .01 ~  2012 .02 .03 :  International Stroke Conference 2012 (New Orleans, USA): Detrimental effect of leptin on intracerebral hemorrhage via STAT3 signal pathway. (Oral Presentation)
• 2011 .05 .24 ~  2011 .05 .27 :  The 20th European Stroke Conference (Hamburg, Germany): A significant association of obesity with cerebral microbleeds in asymptomatic elderly subjects. (Oral Presentation)
• 2008 .11 .21 ~  2008 .11 .23 :  The 4th Japan-Korea Joint Stroke Conference (Fukuoka, Japan): Pulse pressure is an independent predictor of white matter hyperintensities in the healthy elderly. (Oral Presentation)

사회활동

• 2020 .09 .01 ~  2022 .08 .31 :  (주)젠하임바이오텍 CTO

최종수정일 : 2021.11.25